Treatment with VK0214 led to Significant Reductions in Plasma and Tissue Levels of VLCFAs
Good news. ABCD2 making steady progress...
Viking Therapeutics Announces Top-Line Results ... - AMN EASIER
Viking Therapeutics Announces Top-Line Results from Proof-of-Concept Study of VK0214 in In Vivo Model of X-Linked Adrenoleukodystrophy
Written by
wilburlois15
To view profiles and participate in discussions please or .
1 Reply
•
Pretty cool. Thanks so much for sharing!
Not what you're looking for?
You may also like...
Valproic Acid
I've just persuaded my neurologist to prescribe me some Valproic Acid. Surprisingly easy, but...
Fish oil (DHA) + Lorenzo's oil
This is very interesting, read this carefully, especially the conclusion.
I've pasted it below......
vk0214
https://adrenoleukodystrophynews.com/2019/08/06/first-clinical-trial-of-vk0214-for-x-linked-ald-plan
Cell-based Gene Therapy Represents ‘Hope’ for X-ALD Patients, Review Study Suggests
Definitely hopeful for the future of ALD/AMN!...
Tauroursodeoxycholic acid
This was a new one on me. I only Googled it because I liked the name....
Related Posts
REDUCING VLCFA COULD REDUCE SPASMS AND OTHER SYMPTOMS OF AMN.
An Alarming Fall
Vaccine and adrenal glandsModeration team
COwithAMNAdministrator
